Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab
Abstract Background A number of clinical studies focused on treating a single food allergy through oral immunotherapy (OIT) with adjunctive omalizumab treatment have been published. We previously demonstrated safety and tolerability of a rapid OIT protocol using omalizumab in a phase 1 study to achi...
Main Authors: | Sandra Andorf, Monali Manohar, Tina Dominguez, Whitney Block, Dana Tupa, Rohun A. Kshirsagar, Vanitha Sampath, R. Sharon Chinthrajah, Kari C. Nadeau |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13223-017-0223-8 |
Similar Items
-
Feasibility of sustained response through long-term dosing in food allergy immunotherapy
by: Sandra Andorf, et al.
Published: (2017-12-01) -
Immunotherapy and Oral Immunotherapy with Omalizumab for Food Allergies
by: Shoichiro Taniuchi, et al.
Published: (2019-12-01) -
The role of omalizumab in the treatment of adults with severe allergic asthma
by: Sabina Škrgat Kristan
Published: (2013-02-01) -
Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis
by: Luis Santamaria, et al.
Published: (2018-07-01) -
Omalizumab in children with severe allergic disease: a case series
by: Giuseppe Crisafulli, et al.
Published: (2019-01-01)